MarketBeat on MSN

Why AbbVie and Johnson & Johnson Could Outperform Pfizer

Pfizer Inc. (NYSE: PFE) made a strong move higher after it became the first drug manufacturer to sign on as part of the TrumpRx platform. PFE stock is up nearly 14% since its closing price of around ...

Pfizer, J&J urge clarity from FDA on future of COVID-19 vaccine trials once a vaccine is available

Pfizer Inc and Johnson & Johnson are seeking input from a U.S. Food and Drug Administration advisory committee on retaining and attracting volunteers for COVID-19 vaccine trials after a vaccine ...
ABC7 San Francisco

The US is about to get the Johnson & Johnson vaccine. Here's how it's different from the others

The United States is poised to get a third coronavirus vaccine -- this one made by Johnson & Johnson. The US Food and Drug Administration has given the vaccine emergency use authorization, the Centers ...

Johnson & Johnson COVID-19 vaccine produces strong immune response in early trial

A single dose of Johnson & Johnson's experimental COVID-19 vaccine produced a strong immune response against the novel coronavirus in an early-to-mid stage clinical trial, according to interim results ...
TipRanks on MSN

Analyst Sees ‘Attractive Entry Point’ for Johnson & Johnson Stock (JNJ) after Trump-Pfizer Deal

The shares of pharmaceutical giant Johnson & Johnson ($JNJ) rose on Friday afternoon after the stock earned new price boosts ...

What Is Considered a Good Stock Dividend? 3 Healthcare Stocks That Fit the Bill

Here's what you need to know about these three healthcare dividend stocks.